The balance of neural excitation and inhibition (E/I balance) is often hypothesised to be altered in autism spectrum disorder (ASD). One widely held view is that excitation levels are elevated relative to inhibition in ASD. Understanding whether, and how, E/I balance may be altered in ASD is important given the recent interest in trialling pharmacological interventions for ASD which target inhibitory neurotransmitter function.
Introduction
Autism spectrum disorder (ASD) is diagnosed based on the presence of impairments in social interaction and communication, accompanied by restricted and repetitive behaviours (American Psychiatric Association, 2013) . ASD has been reported to affect around 1 in 68 children (Christensen et al., 2016) , yet the precise etiology of the condition is unknown. One hypothesis regarding the pathophysiology of ASD centres on alteration in the balance of neural excitation and inhibition (E/I balance), which is mediated by the effective magnitude and timing of excitatory and inhibitory synaptic inputs to a cortical neuron or network. Due to the widespread consequences that altered E/I balance has for brain function and behaviour (Haider, Häusser, & Carandini, 2013) , E/I imbalance has been suggested as a possible explanation for the behavioural, cognitive and perceptual differences observed in those with ASD. While most accounts suggest that excitation may be increased relative to inhibition in ASD (Coghlan et al., 2012; Hussman, 2001; Markram, Rinaldi, & Markram, 2007; Rubenstein & Merzenich, 2003) , others suggest that inhibition may be increased in ASD relative to excitation (Bertone, Mottron, Jelenic, & Faubert, 2005; Gustafsson, 1997a) .
When evaluating the diverse results of studies which assess E/I balance in ASD, one thing which should be considered is the possibility that an imbalance (or the direction of such imbalance) may not manifest in a ubiquitous way across the condition. ASD is highly heterogeneous, and likely emerges as the consequence of diverse neurobiological sequelae, as is suggested by the many different genetic abnormalities associated with ASD (Miles, 2011) . It is therefore possible that sub-groups of individuals with ASD have specific differences in E/I balance that are not universal, and may contribute to the heterogeneity of the condition.
The suggestion that E/I balance is altered in ASD, and in particular the hypothesis that excitation is increased relative to inhibition in ASD, is largely based on the observation that seizure disorders such as epilepsy frequently co-occur with ASD (Rubenstein & Merzenich, 2003) . Estimates of the prevalence rates of epilepsy in ASD range from 5-46% (Bryson, Clark, & Smith, 1988; Hughes & Melyn, 2005 ) and converge at around 30% (Canitano, 2007) . Subclinical epileptiform activity in the electroencephalography (EEG) is also present in a high proportion of children with ASD (Chez et al., 2006; Hughes and Melyn, (MEG) or EEG, and atypical perceptual function, have been considered to infer E/I imbalance in ASD. An emerging theme from this review is that measuring E/I balance in humans is not straightforward. Many of the claims made regarding altered E/I balance in ASD rely on assumptions, such as assumptions about how alteration of one feature, such as cortical neurotransmitter levels or synaptic protein levels may affect net E/I balance, or assumptions about the extent to which a certain perceptual task reflects E/I balance.
Nevertheless, the collective findings from this body of work certainly imply that E/I balance may be disrupted in ASD, although we would argue that the strength of available evidence is not sufficient to accurately describe the direction of such an imbalance (i.e. whether excitation is increased or reduced relative to inhibition).
Cellular Abnormalities
Arguably, the most compelling evidence for altered E/I balance in ASD comes from studies that have identified abnormalities in anatomical features that are associated with controlling neural excitation and inhibition in ASD. Although many cellular abnormalities have been reported in ASD, this discussion will only highlight examples of the cellular abnormalities found in ASD that are considered to implicate E/I balance (for a more thorough review and diagram of E/I balance at a cellular level, see Coghlan et al., 2012) .
See table 1 for a summary of the studies described in this section.
Neural transmission relies on a complex system of neurotransmitter generation, release, reception and reuptake. In ASD, abnormalities have been found in many of the components of this system. For example found reductions in GABA A receptor density in parietal, cerebellar and superior frontal regions in ASD (see also Blatt et al., 2001; Fatemi et al., 2014 , Oblak et al., 2011 , 2010 , and AMPA-type glutamate receptor density was found to be reduced in the cerebellum of individuals with ASD (Purcell, Jeon, Zimmerman, Blue, & Pevsner, 2001) . There is also evidence that the synthesis of GABA and glutamate is altered in ASD. Glutamic acid decarboxylase (GAD) is an enzyme responsible for catalysing the decarboxylation of glutamic acid to form GABA and exists in two isoforms: 65 and 67 (GAD65; GAD67). Post mortem studies have revealed that both GAD65 and GAD 67 are decreased in the cerebellum and parietal cortex of individuals with ASD (Fatemi et al., 2002; Yip, glutamate-glutamine cycle are decreased in post mortem brain tissue of individuals with ASD, thus also suggesting a dysfunction in excitatory neurotransmission in ASD.
These studies provide strong evidence for the position that E/I balance is likely to be altered in ASD, however, it is hard to predict how a disruption in either receptor density and / or enzyme levels would affect overall E/I balance in ASD. For instance, low levels of GABA receptor expression may be compensated for by higher levels of GABA being released from presynaptic terminals (Dhossche et al., 2002; . Therefore, while this research strongly implicates alteration in mechanisms underpinning E/I balance in ASD, it does not speak clearly to the direction of such an imbalance. Numerous animal models that mimic some aspects of the behavioural symptoms of ASD also display alterations in E/I balance, with altered GABAergic and glutamatergric transmission observed in several studies (for a review see Pizarelli & Cherubini, 2011) . However, whilst Markram et al. (2008) find defective inhibitory transmission in one mouse model of ASD, other models reveal increased inhibitory transmission, or decreased glutamatergic transmission (Blundell et al., 2010; Tabuchi et al., 2007) , demonstrating that even animal models display variable and conflicting results regarding E/I balance in ASD. Decreased GAD67 levels in ASD.
Decreased inhibition.
NT neurotypical.
Cortical Minicolumns
Cortical minicolumns are vertical columns of pyramidal cells which ascend radially through layers VI and II of cortex. They are found in all regions of cortex and constitute the smallest neocortical module capable of processing information (Mountcastle, 1997) . Changes in cortical minicolumns reported in ASD have been linked to E/I balance via the assumption that the precise organisation of the connectivity of the cortex could influence the effective balance of excitation and inhibition. However, while post mortem analysis has revealed that individuals with ASD show minicolumnar abnormalities across widespread regions of the cortex, the precise nature of such abnormality is not consistent across all studies. See table 2 for a summary of these data. For example, some studies have found reduced neuropil space and narrower minicolumn width in frontal and temporal brain regions in ASD (Buxhoeveden et al., 2007; Casanova, Buxhoeveden, Switala, & Roy, 2002a; Casanova, Buxhoeveden, Switala, & Roy, 2002b; Casanova et al., 2006) , whereas a recent study has reported wider minicolumns in sensory, frontal and parietal cortical areas in ASD (McKavanagh, Buckley, & Chance, 2015) .
Neuropil space surrounds the minicolumn core and contains GABAergic inhibitory interneurons (Favorov & Kelly, 1994) which insulate the excitatory flow in the core from the activity of surrounding minicolumns (de Felipe, 1999) . It has therefore been postulated that reduced neuropil space would limit the effectiveness of this inhibitory 'sheath', and lead to reduced neural inhibition in ASD (Casanova, Buxhoeveden, & Gomez, 2003) . However, in contrast to the suggestion that narrower minicolumns in ASD are associated with reduced inhibition, computational modelling work (Gustafsson, 1997b) and experimental studies in cats (Hensch, 2007) , have shown that in fact narrower minicolumns could be associated with increased inhibition.
Minicolumns are a major aspect of neural architecture, and it is likely that differences in their structure would have widespread consequences for E/I balance. Therefore, the finding of altered minicolumns in ASD is important. However, despite a tendency in the literature for researchers to cite minicolumn abnormalities as evidence for E/I imbalance, and typically increased excitation relative to inhibition, in ASD, it is clear that there is no consensus in the literature regarding how minicolumns are altered in ASD, nor how altered minicolumnar structure may relate to E/I balance. Decreased inhibition.
NT neurotypical. a Results are interpreted in line with evidence that wider minicolumns reflect decreased inhibition (Gustafsson, 1997b , Hensch, 2007 . However, see the text for a full discussion of the interpretation of these findings.
Blood Measurement
Several ASD studies have attempted to quantify glutamate and GABA levels via blood measurements, although results are inconsistent (see table 3 for a summary of these studies). Blood plasma glutamate levels have been found to be increased (Hassan et al., 2013) and platelet levels of its precursor glutamine, decreased (Rolf, Haarmann, Grotemeyer, & Kehrer, 1993) in participants with ASD compared to neurotypical controls. Similarly, whilst Dhossche et al (2002) reported higher blood plasma GABA levels in children with ASD, decreased platelet levels of GABA have also been reported (Rolf et al., 1993) . Further difficulty in interpretation of such studies arises from the fact that amino acid neurotransmitters do not easily cross the blood-brain barrier, and as such it is difficult to interpret the results of studies which measure glutamate and GABA levels in this way in terms of neural E/I balance within the brain (see also Rojas, Becker & Wilson, 2015) . 
Dhossche et al. (2002)
ASD: 9 (7.8) ADHD: 9 (10.5)
Blood plasma levels of GABA.
Increased GABA levels in ASD.
Increased inhibition.
Hassan et al. (2013)
ASD: 10 (11.4) NT: 10 (11.3).
Blood plasma levels of glutamate.
Increased glutamate levels in ASD.
Increased excitation.
Rolf et al. (1993)
ASD: 18 ASD (9.9) NT: 14 (11.5)
Platelet levels of glutamine (glutamate precursor).
Decreased glutamine levels in ASD.
Decreased excitation.
Platelet levels of GABA. Decreased GABA levels in ASD. 
Glutamate / Glx
Several studies have measured resting levels of glutamate and/or Glx levels in ASD, however, results vary with respect to whether glutamate / Glx is increased or decreased in ASD compared to neurotypical controls. Rojas, 2013) ; and the cerebellum; striatum and frontal lobe (Hassan et al., 2013) . However, other studies have found decreased glutamate/Glx in ASD in regions including the ACC (Bernardi et al., 2011; van Elst, Maier, Fangmeier, & Endres, 2014 ) the basal ganglia (Horder et al., 2013) ; frontal and occipital cortex, the cerebellum (Devito et al., 2007) and white matter (Corrigan et al., 2013 ). Yet other studies have found no significant differences in glutamate / Glx levels between individuals with and without ASD in several different brain regions including parietal lobes (Horder et al., 2013; Page et al., 2006) , frontal lobes (Horder et al., 2013) temporal lobes (Devito et al., 2007) , and occipital lobes (Robertson, Ratai, & Kanwisher, 2015) ; the thalamus (Bernardi et al., 2011; Doyle-Thomas et al., 2014; Hardan et al., 2008) ; hippocampus (Joshi et al., 2012); and cerebellum (van Elst et al., 2014) . Therefore, the literature regarding glutamate/Glx levels in ASD is mixed. Even measuring glutamate/Glx levels from the same structure has yielded inconsistent results (c.f. DeVito et al., 2007; Hassan et al., 2013) .
GABA
Fewer studies have attempted to measure cortical GABA levels in ASD. Although results appear to be more consistent than when measuring glutamate/Glx. For example, decreased GABA levels in individuals with ASD compared to controls have been reported in motor (Gaetz et al., 2014) and auditory cortex (Gaetz et al., 2014; Rojas, Singel, Steinmetz, Hepburn, & Brown, 2014) , and in the ACC (Cochran et al., 2015) , although Brix et al. (2015) found no differences in GABA levels in the ACC. Other regions, such as the occipital cortex show no differences in GABA levels between participants with and without ASD (Gaetz et al., 2014; Robertson et al., 2015) .
Implications for E/I balance
There is no clear picture regarding how glutamate / Glx levels may be altered in ASD. There is more support for reduced cortical GABA levels in ASD, although this does not appear to be consistent across the cortex.
Nevertheless, it is difficult to predict the resultant effect of any alteration in neurotransmitter levels on the net balance of E/I due to the complex interactions between the level of a single inhibitory neurotransmitter and compensatory excitatory mechanisms (Levin & Nelson, 2015) . Even within an individual, neurotransmitter levels vary between different cortical areas (Gao et al., 2013) , and over time (e.g. with the menstrual cycle, Epperson et al., 2002) adding further complexity to the task of investigating E/I balance by studying neurotransmitter levels alone. There are also limitations to the MRS technique. For instance, GABA measurement in particular is difficult due to overlap between its resonance spectra and those of creatine and other macromolecules (Puts & Edden, 2012) , and it can be difficult to localise the relatively large area of brain (typically 3cm 3 ) measured using MRS to a particular brain structure, which may lead to differences between studies. Therefore, while the available evidence provides some evidence that excitatory and inhibitory neurotransmitter levels may be altered in ASD relative to neurotypical controls, the precise nature of any such alteration, and the direct consequence of this for E/I imbalance remain unclear. Glx and glutamate levels increased in ASD.
Cochran et al. (2015)
ASD: 13 (14.9) NT: 14 (14.7)
GABA, glutamate and glutamine levels in anterior cingulate cortex.
Increased glutamine and decreased GABA levels in ASD.
Corrigan et al. (2013)
ASD: 45 (4) NT: 10 (3.8) Developmental Delay: 13 (3.9)
Glx levels in grey and white matter.
Decreased Glx levels in white matter in ASD.
ASD: 31 (6.6) NT: 18 (6.6) Developmental Delay: 14 (6.4) Glx levels in grey and white matter.
No group difference. No difference.
ASD: 29 (9.6) NT: 29 (9.6) Glx levels in grey and white matter.
No group difference. No difference. Glx levels measured in putamen.
Increased Glx in ASD.
Gaetz et al. (2014)
ASD: 17 (11.5) NT: 15 (12.7)
GABA levels in left auditory cortex.
Decreased GABA levels in ASD.
ASD:13 (12.2) NT: 11 (11.1) GABA levels in left motor cortex.
ASD: 8 (13) NT:10 (13.3)
GABA levels left and right visual cortex.
No group differences. No difference. .
Hardan et al. (2008)
ASD: 18 (11.6) NT: 16 (11.9)
Glutamate levels in the thalamus.
No group differences. No difference. Increased glutamate in ASD.
Increased excitation. NT neurotypical; ND narrowly defined phenotype; BP broader phenotype.
Hassan et al. (2013)
ASD: 10 (11.4) NT: 10 (11.3) Glutamate levels measured in left frontal lobe.
High frequency neural oscillations (gamma-band activity)
Gamma-band activity (30+Hz) is thought to be generated by the activity of inhibitory GABA-ergic interneurons in neuronal networks involving excitatory pyramidal cells and inhibitory interneurons (Bartos, Vida, & Jonas, 2007; Cardin et al., 2009; Traub et al., 1998; Whittington, Traub, Kopell, Ermentrout, & Buhl, 2000; Whittington & Traub, 2003) . A number of authors have therefore suggested that gamma activity recorded through either EEG or MEG provides insight into the dynamics of E/I balance at a network level (e.g. Snijders et al., 2013) . The vast majority of studies investigating gamma activity in ASD have measured gamma power, i.e. changes in the magnitude of gamma amplitude associated with the presentation of a stimulus (e.g. evoked or induced gamma power), or spontaneous gamma power recorded while participants are awake but at-rest. All of the studies described in this section are summarized in table 5.
This work has shown that spontaneous gamma power is increased in ASD ( been shown to lead to increased gamma band power (Lewis et al., 2008) . Therefore spontaneous gamma power in ASD may reflect increased GABA levels. However, other evidence suggests that this may not be the case, as Yizhar and colleagues showed that optogenetically increasing excitation in the prefrontal cortex of mice resulted also in an increase in the spontaneous gamma power of the local field potential (Yizhar et al., 2011). Thus the relationship between E/I balance and spontaneous gamma power does not appear to be straightforward..
When considering papers that report task-or stimulus-related changes to gamma power in ASD, results are much less consistent. Changes in M/EEG spectral power elicited by stimuli can be divided into two main categories: evoked and induced (Galambos, Basar, & Bullock, 1992) . Evoked activity is both phase-locked and time-locked to the onset of a stimulus; induced activity often occurs later than evoked activity, and whilst it is time-locked it is not phase-locked to the stimulus. While several studies have found evoked gamma band power to be reduced in ASD (Edgar et al., 2015; Baruth et al., 2010; Rojas, Maharajh What do changes in evoked and / or induced gamma band power suggest about E/I balance in ASD? There is little existing data that allows us to confidently link evoked gamma power to E/I balance, although one study suggests that evoked gamma power may be associated with glutamate levels, as Lally et al. (2014) have reported a positive correlation between dynamic glutamate levels (measured using MRS) and evoked gamma band power (measured using EEG recorded from parietal and occipital electrodes; Lally et al., 2014) . Therefore, evidence for reduced evoked gamma power may tentatively suggest decreased glutamate levels in ASD.
There are more studies that have investigated associations between E/I balance and induced gamma power, but findings are inconsistent. In line with the role of inhibitory interneurons in generating gamma band activity, a positive correlation between GABA levels in superior temporal sulcus (measured using MRS) and the power of induced gamma band oscillations has been reported (Balz et al., 2016) , suggesting that increased induced gamma band power is associated with higher GABA levels. This position is also supported by pharmalogical manipulations of GABA, as administration of propofol (a GABA agonist) leads to an increase in induced gamma band power (Saxena, Muthukumaraswamy, & Diukova, 2013) . However, other studies have not found any association between GABA levels (in occipital cortex) and induced gamma band power (Cousijn et al., 2014; Muthukumaraswamy, Edden, Jones, Swettenham, & Singh, 2009 ). Therefore currently, it seems that little can be learnt about E/I balance by measuring gamma power in ASD.
An additional metric of gamma band activity is peak induced gamma frequency. Peak gamma frequency has been more precisely linked to E/I balance than gamma power via computational modelling work (Brunel et al., 2014) . For instance, higher levels of inhibition have been shown to lead to a higher peak gamma frequency (Brunel et al., 2014) . Peak gamma frequency has been shown to be stable over time, and also to be highly heritable (van Pelt, Boomsma, & Fries, 2012), therefore peak gamma frequency may represent a more useful way to investigate E/I balance in human participants. Some studies have shown that visuallyinduced peak gamma frequency is correlated with resting GABA levels in occipital cortex Gaetz, Edgar, Wang, & Roberts, 2011; Muthukumaraswamy et al., 2009 ) although others have failed to replicate this relationship (Cousijn et al., 2014; Saxena et al., 2013) . The technical difficulty in measuring GABA concentration in vivo with MRS and the different scan parameters used in these studies may contribute to the lack of convergence in results, Nevertheless, peak gamma frequency elicited by visual stimuli has been found to be higher in ASD (Dickinson et al., 2016) , and correlated with autistic traits in the neurotypical population (Dickinson, Bruyns-Haylett, Jones, & Milne, 2015) . In light of previous literature Muthukumaraswamy et al., 2009) this suggests that inhibition is increased in participants with ASD. As described below, orientation discrimination thresholds were also found to be decreased in the same cohort of participants with ASD, which concurs with the suggestion that inhibition is increased in these participants.
Taken together therefore, results arising from studying gamma band activity in ASD are inconclusive with regard to E/I balance. One difficulty is that it is not clear exactly how increases or decreases in gamma power should be interpreted with regards to E/I balance, nor is it clear to what extent gamma power is altered in ASD. Gamma frequency, as opposed to gamma power, represents a potentially more fruitful avenue to investigate E/I balance, although to date only one study has measured differences in peak gamma frequency between those with and without ASD. No group differences (30-50Hz).
No difference.
Gross et al. (2012)
ASD: 10 (14.1) NT:11 (14.8) Induced activity elicited by faces measured over parietal areas (EEG).
Decreased induced gamma power in ASD (35-45Hz).
Decreased inhibition. Evoked activity elicited by Mooney faces measured over fronto-central areas (MEG).
Machado et al. (2013)
Increased (25-60Hz) in ASD.
Sun et al. (2012)
ASD : Induced gamma activity elicited by faces measured over occipital areas (MEG).
Decreased induced gamma activity in ASD (30-80Hz).
Wright et al. (2012)
ASD: 13 (15.1) NT: 13 (15.7)
Evoked gamma activity elicited by faces measured over occipital areas (MEG) .
No group differences in evoked activity (30-80Hz).
NT neurotypical; LD learning difficulties. a Results are interpreted in line with increased gamma activity indicating increased inhibition (e.g. Cardin et al., 2009 ). However, see the text for a more in depth discussion regarding how E/I balance is reflected by gamma activity.
Perception
Within the visual psychophysics literature, a substantial body of work suggests a link between perception and excitatory and / or inhibitory neurotransmission. Given this association, some authors have suggested that measuring aspects of perception in ASD may provide a marker for measuring E/I balance in the autistic brain (Freyberg, Robertson, & Baron-Cohen, 2015) . As described below (see table 6 for a summary), phenomena that are most directly linked to E/I balance include binocular rivalry, spatial suppression / gain control, and orientation discrimination. However, as with the EEG / MEG data described above, these data provide only indirect evidence for E/I imbalance in ASD, and, collectively, do not converge on a clear direction for any such imbalance.
Binocular Rivalry
Binocular rivalry is a perceptual phenomenon which occurs when a different image is presented to each eye simultaneously. Rather than perceive a stable superimposition of the two images, the participant randomly perceives each image separately for a few moments although combinations of the two images may be perceived during transitions between the two percepts (Wheatstone, 1850) . Computational models have
shown that changes to E/I balance could lead to alterations in rivalry dynamics including: the rate of switches between two percepts; how long an individual percept is experienced; how long a mixed percept is experienced; and / or the length of the transition period between the two images (travelling wave speed; Laing and Chow, 2002; Seely and Chow, 2011; Wilson et al., 2001) . For example, modelling work has shown that a higher level of excitation would lead to faster rivalry dynamics, due to faster travelling waves (Wilson et al., 2001 ). This is supported by the finding that administration of lorazepam (a GABA agonist) decreases the rate of perceptual switches suggesting that higher levels of inhibition lead to slower rivalry dynamics (van Loon, Knapen, Scholte, & John-Saaltink, 2013 ).
To our knowledge, four studies have measured binocular rivalry in individuals with ASD. Three of these studies have found significant differences in binocular rivalry in ASD compared to neurotypical individuals (Freyberg et al., 2015; Robertson, Kravitz, Freyberg, Baron-Cohen, & Baker, 2013; Robertson et al., 2015) , and one study found no differences (Said, Egan, Minshew, Behrmann, & Heeger, 2013) . Where differences between individuals with and without ASD have been found, data concur to suggest 'slower' binocular rivalry in ASD, which is characterised by a reduced switching rate due to a longer time perceiving mixed percepts (Freyberg et al., 2015; Robertson et al., 2013 Robertson et al., , 2015 . Robertson and colleagues (2015) report that there is a decreased rate of perceptual suppression in ASD, which manifests as a larger amount of time perceiving a mixed percept, and less time perceiving an individual percept. When considered alongside their finding that occipital GABA level is correlated with perceptual suppression in neurotypical participants, this would indicate that decreased levels of occipital GABA may be present in ASD. However, individual differences in occipital GABA levels did not correlate with perceptual suppression in participants with ASD.
Furthermore, there were no differences in occipital GABA levels between the participants with and without ASD, despite finding differences in binocular rivalry . Robertson and colleagues conclude from these data that an aspect of GABA functioning, which is not captured by MRS, is atypical in ASD, and that this leads to the observed differences in binocular rivalry. However, it is unclear from these data what such an unobserved difference may be. Taken together, slower perceptual rivalry in ASD may
suggest atypical E/I balance in ASD, but it is not entirely clear whether this finding reflects increased or decreased excitation relative to inhibition.
Spatial suppression and gain control
Spatial suppression refers to the fact that an increase in stimulus size can lead to a decrease in how easily stimuli are perceived (Tadin et al., 2003) . The phenomenon relies on centre surround suppression, meaning that decreased inhibition would lead to weaker spatial suppression, and a reduced effect of increasing stimulus size on perception (Golomb et al., 2009 ). Foss-Feig et al. (2013 investigated spatial suppression in individuals with and without ASD using a motion discrimination paradigm in which participants were asked to indicate the direction of drifting gratings that varied in size and contrast. It was predicted that if inhibitory mechanisms are altered in ASD, differences in spatial suppression would be seen between the participants with and without ASD. However, spatial suppression was found to be unaltered in ASD. There was however an interesting effect of stimulus contrast in this study, as although participants with ASD showed similar results to controls for low contrast stimuli, they performed systematically better than controls when stimuli were presented at high contrast (regardless of size). It was suggested that this pattern of performance indicates abnormal gain control in ASD. Like spatial suppression, gain control is thought to reflect an inhibitory mechanism: specifically, the saturation of neural responses at high contrast (Albrecht & Hamilton, 1982) . This has been found to be weakened when gabazine (a GABA A antagonist) is topically applied to the visual cortex of cats (Katzner, Busse, & Carandini, 2011) . Therefore, although spatial suppression was unaltered in ASD, the weakening of response gain in ASD may therefore indicate decreased GABA levels, and therefore reduced inhibition in ASD.
Perceptual Discrimination
In contrast to the conclusion made by Foss-Feig et al. (2013) , evidence from perceptual discrimination may suggest increased inhibition in ASD. For example, as described below, superior orientation discrimination and superior pitch discrimination have been reported in ASD, both of which are associated with increased inhibitory neurotransmission.
We have recently found that orientation discrimination thresholds are decreased in adults with ASD (Dickinson et al., 2016 , although see Schwarzkopf, Anderson, de Haas, White, & Rees, 2014 Shafai, Armstrong, Iarocci, & Oruc, 2015) , and also that orientation discrimination thresholds correlate with autistic traits in the neurotypical population (Dickinson, Jones, & Milne, 2014) . Inhibitory mechanisms are implicated in orientation discrimination as they are known to be involved in tuning the orientation selectivity of cells, as orientation selective neurons become narrowly tuned to a particular orientation through lateral inhibition (Hubel & Wiesel, 1968) , and GABAergic inhibition has been shown to directly influence orientation discrimination ability. For example, topical application of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) to neurons in the primary visual cortex of anaesthetised cats leads to orientation selective cells becoming more narrowly tuned, and increases their orientation selectivity (Li et al., 2008) . Conversely, the application of GABA antagonists reduces the orientation selectivity of cells in primary visual cortex (Katzner et al., 2011; Sillito, 1975) . Resting levels of GABA in the occipital cortex are also inversely correlated with orientation discrimination thresholds in neurotypical human observers suggesting that GABA mediated inhibition plays a major role in establishing the sharp orientation tuning of neurons, and leads to enhanced orientation discrimination. Therefore our finding of enhanced orientation discrimination in ASD is consistent with inhibition being increased rather than decreased in ASD.
Other aspects of perceptual discrimination, such as hue discrimination, are impaired, rather than enhanced in ASD (Franklin et al., 2010; Franklin, Sowden, Burley, Notman, & Alder, 2008; Heaton, Ludlow, & Roberson, 2008) . Although, again, this is in-line with the suggestion of increased inhibition given that medication which increases GABA levels, such as vigabatrin, has been shown to lead to colour perception impairments in healthy individuals (Mecarelli, Rinalduzzi, & Accornero, 2001 ). In the auditory domain, pitch discrimination is enhanced in ASD (Bonnel et al., 2003 (Bonnel et al., , 2010 Heaton, Hudry, Ludlow, & Hill, 2008; Jones et al., 2009; Meilleur, Berthiaume, Bertone, & Mottron, 2014; O'Riordan & Passetti, 2006; Stanutz, Wapnick, & Burack, 2014) . Similar to orientation discrimination, pitch discrimination is mediated by lateral inhibition (Houtgast, 1972) , as auditory cortex cells also become more narrowly tuned to particular frequencies through inhibition (Wang, Caspary, & Salvi, 2000; Wang, Ding, & Salvi, 2002) , suggesting increased inhibition in ASD However, some studies find that enhanced pitch discrimination occurs only in a subgroup of individuals with ASD (Bonnel et al., 2010; Jones et al., 2009) . Taken together with studies that find orientation discrimination to be unaltered in ASD (Schwarzkopf, Anderson, de Haas, White, & Rees, 2014; Shafai, Armstrong, Iarocci, & Oruc, 2015) this may suggest that superior perceptual discrimination, and increased inhibition, occurs only in a sub-group of individuals with ASD. Impaired colour discrimination in ASD.
Freyberg et al. (2015)
ASD: 26 (32) NT: 27 (28.7) Binocular rivalry.
Reduced switch rate due to longer mixed percepts.
Increased excitation. Superior pitch discrimination in ASD.
Heaton et al. (2008)
ASD:13 (11.4) LD: 13 (11.5) NT: 13 (11) Colour discrimination.
Impaired colour discrimination in ASD.
Increased inhibition. increase in inhibition, a net increase in excitation, or no difference in E/I balance.
Jones et al. (2009)
ASD
Conclusion
Alteration of E/I balance has been suggested as a possible neural mechanism underlying the symptoms of ASD. As this review demonstrates, there is much evidence to suggest that excitatory and inhibitory neurotransmission is altered in ASD. However, results do not concur with respect to the direction of E/I imbalance in ASD. This is illustrated in figure 1 , which demonstrates the number of findings from studies in each section of this article which concur with either a net increase in inhibition (either through increased inhibition or decreased excitation), a net increase in excitation (either through increased excitation or dressed inhibition), or no difference in E/I balance. A recurring theme in the literature is that despite no unequivocal demonstration that either inhibition or excitation is increased in ASD, there appears to be an a priori assumption in many papers that there is clear existing evidence for increased excitation in ASD.
Consequently many new research findings are interpreted in this context, without due consideration of the assumptions underlying linking certain techniques to measuring E/I balance.
Three further important points arise from this review. Firstly, each of the methods used to measure or infer E/I balance in ASD has a number of limitations and can provide only one small piece of evidence in a very large puzzle. Secondly, it is possible that E/I balance is altered in different ways in different areas of the brain in ASD, and thirdly, it is possible that there are different sub-types of ASD that have different neural profiles with respect to E/I balance.
Given the inherent difficulty in measuring E/I balance in vivo, a valuable way forward would be to utilise multiple methodologies within the same study. For instance, obtaining multiple data points from individual participants may strengthen conclusions by finding converging results. To date two studies, described above, have taken this approach. Robertson et al (2016) measured binocular rivalry and also occipital GABA levels in ASD. In this study, slower binocular rivalry indicated disruption to E/I balance in ASD, although no group differences were found in occipital GABA levels. Dickinson et al. (2016) found a significant difference between orientation discrimination thresholds and peak gamma frequency in ASD, concluding that both variables pointed towards increased inhibition in ASD. Future studies could be much more ambitious in this regard, and it is hoped that future researchers will be able to obtain data from multiple methodologies from the same individual in order to more clearly identify the way in which E/I balance is altered in ASD (if at all). For example, a multi-technique study which examines sensory discrimination thresholds within different modalities (such as pitch discrimination and orientation discrimination) as well as measuring neurotransmitter levels in different sensory cortices would be an effective way to address whether E/I balance is altered in a consistent way across different areas of the cortex.
To conclude, we have provided an overview of data emerging from a range of techniques that purport to measure E/I balance in ASD. While there is clear evidence that disruption to E/I balance is implicated in ASD, the direction of any such imbalance is less clear. Crucially, this may be important in understanding the variability seen in response to clinical trials of drugs that attempt to modulate E/I balance in ASD (Erickson et al., 2014) . The data reviewed here highlight the importance of ambitious future research, which will obtain data from a range of different methodologies from large samples of participants. As far as we can see, this will be the most effective way to reveal the true landscape of E/I imbalance in ASD.
